Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma

Autor: Huanqin Li, Shumin Liu, Yun Lin, Xiongfei Shi, Na Du, Jing Yao, Ruiyang Liu, Yan Du, Kai Yang

Publikováno v: Intervirology, Pp 1-11 (2022)

Introduction: Accumulated studies have suggested that hepatitis C virus (HCV) infection is one of the leading causes for hepatocellular carcinoma (HCC). However, the mechanisms underlying the effect of HCV on the occurrence of HCC are still poorly un

Externí odkaz: https://doaj.org/article/d6a30b3544184bd5aa9bbc406987b31f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling

Autor: Yunong Wu, Gang Li, Junbo Zhou, Hongchuang Zhang, Jinhai Ye, An Song, Enshi Yan, Xiaomeng Song, Yi Wang, Feng Jiang, Yang Zheng, Xu Ding

Publikováno v: Molecules and Cells

Ubiquitin D (UBD) is highly upregulated in many cancers, and plays a pivotal role in the pathophysiological processes of cancers. However, its roles and underlying mechanisms in oral squamous cell carcinoma (OSCC) are still unclear. In the present st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ec97d769b61d7cf210271c49d88224
https://doi.org/10.14348/molcells.2021.2229

شناسایی یوبیکوئیتین D از بافت‌های پارافینه، در بیماران مبتلا به سرطان روده‌ی بزرگ

Autor: Amir Izadi, Elham Moslemi, Seyed Mohammad Poorhosseini, Vahid Reza Yassaee, Hamid Reza Kheiri, Hamid Reza Elikai

Publikováno v: مجله دانشکده پزشکی اصفهان, Vol 32, Iss 291, Pp 972-981 (2014)

مقدمه: سرطان روده یکی علل مهم مرگ و میر ناشی از سرطان است. یوبیکوئیتین (UBD یا Ubiquitin D) و پروتئین‌های شبه یوبیکوئیتین، ناقلان سیگنال رسانی هس�

Externí odkaz: https://doaj.org/article/33bafdbcef074059a5fffbc00b8c3887

Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma

Autor: Markus von Flüe, Charlotte K.Y. Ng, L. Terracciano, John Gallon, Tujana Boldanova, Salvatore Piscuoglio, Sandro Nuciforo, Augusto Villanueva, Josep M. Llovet, Viola Paradiso, Mairene Coto-Llerena, Sergio Rodríguez-Tajes, Savas D. Soysal, Otto Kollmar, Markus H. Heim, Gaia Bianco, Marie-Anne Meier, Sofía Pérez-del-Pulgar, Stephanie Taha-Melitz, Caner Ercan

Publikováno v: Gallon, John; Coto-Llerena, Mairene; Ercan, Caner; Bianco, Gaia; Paradiso, Viola; Nuciforo, Sandro; Taha-Melitz, Stephanie; Meier, Marie-Anne; Boldanova, Tujana; Pérez-Del-Pulgar, Sofía; Rodríguez-Tajes, Sergio; von Flüe, Markus; Soysal, Savas D; Kollmar, Otto; Llovet, Josep M; Villanueva, Augusto; Terracciano, Luigi M; Heim, Markus H; Ng, Charlotte K. Y. and Piscuoglio, Salvatore (2022). Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma. Molecular oncology, 16(3), pp. 665-682. Wiley 10.1002/1878-0261.13154
Molecular Oncology
Molecular Oncology, Vol 16, Iss 3, Pp 665-682 (2022)

Hepatocellular carcinomas (HCCs) usually arise from chronic liver disease (CLD). Precancerous cells in chronically inflamed environments may be ‘epigenetically primed’, sensitising them to oncogenic transformation. We investigated whether epigene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da8e8e1a5475c499293d431f28e9056b
https://boris.unibe.ch/162331/1/Molecular_Oncology_-_2021_-_Gallon_-_Epigenetic_priming_in_chronic_liver_disease_impacts_the_transcriptional_and_genetic.pdf